Neutropenic fever: Difference between revisions

No edit summary
Line 1: Line 1:
==Background==
==Background==
ANC = (total WBC) x (%segs + %bands)
*ANC = (total WBC) x (%segs + %bands)
*Nadir usually occurs 5-10d after chemo
*Duration of neutropenia depends on type of cancer treatment
**Solid tumor Rx: <5d
**Hematologic malignancies: 14d or longer
*(Leukemia or lymphoma) + chemo most commonly associated with neutropenia
 
===Definition===
===Definition===
#ANC <500 OR <1000 w/ predicted nadir of <500 in 48h
#ANC <500 OR <1000 w/ predicted nadir of <500 in 48h AND
#AND
#Fever ≥ 38.3˚C (100.9˚F) once OR sustained temp ≥38 (100.4) for >1hr
#Fever ≥ 38.3˚C (101˚F) once OR sustained temp ≥38 (100.4) for >1hr
##Oral temp (do not obtain rectal temp)
##Oral temp (do not obtain rectal temp)
===Pathophysiology===
*Nadir usually occurs 7-10d after chemo
*Duration of neutropenia depends on type of cancer treatment
**Solid tumor Rx: ~<5d
**Hematologic malignancies: ~14d or longer
#Leukemias, lymphomas + chemo most commonly associated with neutropenia


===Common Causes===
===Common Causes===
Line 21: Line 19:
##Staph, strep
##Staph, strep
#Respiratory tract
#Respiratory tract
##Step pneumo, Klebsiella, Corynebacterium, Pseudomonas
##Step pneumo, klebsiella, corynebacterium, pseudomonas
#Other
#Other
##C dif, Mycobacterium, Candida, Aspergillus
##C. diff, mycobacterium, candida, aspergillus


==Diagnosis==
==Diagnosis==
#Classic manifestations of infxn NOT seen
#Classic manifestations of infection are frequently NOT seen
#Check skin, mucosa, sinuses, indwelling cath sites
#Check skin, oral cavity, perianal area, entry sites of indwelling cath sites
##Mild erythema, slight erosion in oropharynx or perianal area


==DDx==
==DDx==
Line 39: Line 36:
#CBC
#CBC
#Chemistry
#Chemistry
#LFT
#LFTs
#UA (may not show WBCs or leuk esterase given neutropenia), UCx
#UA/UCx
#Sputum gram stain and Cx
##May not show WBCs or leuk esterase given neutropenia
#BCx x 2 (20-30cc blood (adult) or 3-9cc (child); may take both samples from CVC
#Sputum studies
##Gram stain
##Cx
#BCx x 2
##20-30cc blood (adult); 3-9cc (child)
##May take both samples from CVC (if present)
#Cx any indwelling catheters
#Cx any indwelling catheters
#LP (if neuro abnl or suspicious)
#LP
##If neuro abnl or suspicious
#Site-specific specimens
#Site-specific specimens
##Nasopharyngeal wash in pts with UR (RSV, influenza)
##Nasopharyngeal wash (in pts with URI)
###RSV, influenza
#Stool (if indicated)
#Stool (if indicated)
##C dif
##C dif
Line 52: Line 56:
##Cx
##Cx
#CXR
#CXR
#CT if necessary
#CT (if necessary)
##Sinuses
##Sinuses
##Chest
##Chest
Line 62: Line 66:
#Hepatosplenocandidiasis
#Hepatosplenocandidiasis
##After neutropenic fever resolves and ANC has come up allowing abcess formation
##After neutropenic fever resolves and ANC has come up allowing abcess formation
##Rx ampho b
##Treat w/ amphotericin B


==Treatment==
==Treatment==
*If suspect infection then treat (even if afebrile)
#If suspect infection then treat (even if afebrile)
*3rd or 4th gen cephalosporin (cefepime 2g or ceftazidime 2g) OR
##3rd or 4th gen cephalosporin (cefepime 2g or ceftazidime 2g) OR
*Carbapenem (imipenem 500mg or meropenem 1g) OR
##Carbapenem (imipenem 500mg or meropenem 1g) OR
*Zosyn 4.5g +/- aminoglycoside (gent 2-5mg/kg, amikacin) OR
##Zosyn 4.5g +/- aminoglycoside (gent 2-5mg/kg, amikacin) OR
*Antipseudomonal fluoroquinolone (moxi, levo, cipro) +/- vanco
##Antipseudomonal fluoroquinolone (moxi, levo, cipro) +/- vanco
 
#Add Amphotericin B 0.5-1 mg/kg qd if fever >72 h or candida in esophagus, urine or stool
#hypotension
#Add anaerobic coverage (clindamycin, metronidazole) if peritonitis or abd pain
#Grm + Bcx
#Hx of MRSA or Bactrim resistant pneumococci
#Prior ppx with fluoroquinolone or Bactrim
#Catheter related infxn
 
*Add Amphotericin B 0.5-1 mg/kg qd if fever >72 h or candida in esophagus, urine or stool
 
*Add anaerobic coverage (clindamycin, flagyl) if peritonitis or abdominal symptomatology occurs
 
*If PMNs expected to be ≤ 100/mm3 for one week, consider G-CSF/GM-CSF
**Unless pt has hx of leukemia, in which case G-CSF is generally contraindicated
*No current evidence supports antifungals or antivirals if fever alone; after 4-7 days may need to start either/both


==Disposition==
==Disposition==
*Low Risk patients
*Low risk patients
**D/c home using Multinational Association for Supportive Care in Cancer (MASCC) risk index:
**D/c using Multinational Association for Supportive Care in Cancer (MASCC) risk index


===Patient Clinical Factor Score===
===Patient Clinical Factor Score===
Line 127: Line 118:


≥21 pt = low risk for SBI
≥21 pt = low risk for SBI
===Out Patient===
Home with close onc f/u and abx:
#Cipro 500 Q8H
#AND, Augmentin 500 Q8H
===In Patient===
ADMIT all other patients (majority)


==Source==
==Source==
Pani 6/09, DeBonis 3/10
LLSA 2009; Halfdanarson Onc Emergencies Mayo Clin Proc June 2006
 
*Tintinalli
Reference: LLSA 2009; Halfdanarson Onc Emergencies Mayo Clin Proc June 2006; EMP


[[Category:Heme/Onc]]
[[Category:Heme/Onc]]
[[Category:ID]]
[[Category:ID]]

Revision as of 02:49, 23 October 2011

Background

  • ANC = (total WBC) x (%segs + %bands)
  • Nadir usually occurs 5-10d after chemo
  • Duration of neutropenia depends on type of cancer treatment
    • Solid tumor Rx: <5d
    • Hematologic malignancies: 14d or longer
  • (Leukemia or lymphoma) + chemo most commonly associated with neutropenia

Definition

  1. ANC <500 OR <1000 w/ predicted nadir of <500 in 48h AND
  2. Fever ≥ 38.3˚C (100.9˚F) once OR sustained temp ≥38 (100.4) for >1hr
    1. Oral temp (do not obtain rectal temp)

Common Causes

  • Definitive cause only found in 30%
  1. Endogenous flora 80%
    1. E Coli, Enterobacter, anaerobes
  2. Skin
    1. Staph, strep
  3. Respiratory tract
    1. Step pneumo, klebsiella, corynebacterium, pseudomonas
  4. Other
    1. C. diff, mycobacterium, candida, aspergillus

Diagnosis

  1. Classic manifestations of infection are frequently NOT seen
  2. Check skin, oral cavity, perianal area, entry sites of indwelling cath sites

DDx

  1. Transfusion reaction
  2. Medication allergies and toxicities
  3. Tumor-related fever

Work-Up

  1. AVOID rectal temp
  2. CBC
  3. Chemistry
  4. LFTs
  5. UA/UCx
    1. May not show WBCs or leuk esterase given neutropenia
  6. Sputum studies
    1. Gram stain
    2. Cx
  7. BCx x 2
    1. 20-30cc blood (adult); 3-9cc (child)
    2. May take both samples from CVC (if present)
  8. Cx any indwelling catheters
  9. LP
    1. If neuro abnl or suspicious
  10. Site-specific specimens
    1. Nasopharyngeal wash (in pts with URI)
      1. RSV, influenza
  11. Stool (if indicated)
    1. C dif
    2. O&P
    3. Cx
  12. CXR
  13. CT (if necessary)
    1. Sinuses
    2. Chest
    3. A/P

High-Risk/Special Infections

  1. Neutropenic enterocolitis (typhlitis)
  2. Zygomycosis (see Mucormycosis)
  3. Hepatosplenocandidiasis
    1. After neutropenic fever resolves and ANC has come up allowing abcess formation
    2. Treat w/ amphotericin B

Treatment

  1. If suspect infection then treat (even if afebrile)
    1. 3rd or 4th gen cephalosporin (cefepime 2g or ceftazidime 2g) OR
    2. Carbapenem (imipenem 500mg or meropenem 1g) OR
    3. Zosyn 4.5g +/- aminoglycoside (gent 2-5mg/kg, amikacin) OR
    4. Antipseudomonal fluoroquinolone (moxi, levo, cipro) +/- vanco
  2. Add Amphotericin B 0.5-1 mg/kg qd if fever >72 h or candida in esophagus, urine or stool
  3. Add anaerobic coverage (clindamycin, metronidazole) if peritonitis or abd pain

Disposition

  • Low risk patients
    • D/c using Multinational Association for Supportive Care in Cancer (MASCC) risk index

Patient Clinical Factor Score

Patient Clinical Factor Score

Severity of illness:

no symptoms or mild symptoms

moderate symptoms

5

3

No hypotension
5
No chronic obstructive pulmonary disease
4
Solid tumor or no fungal infxn
4
No dehydration
3
Outpt at onset of fever
3
Age < 60yo
2

≥21 pt = low risk for SBI

Source

LLSA 2009; Halfdanarson Onc Emergencies Mayo Clin Proc June 2006

  • Tintinalli